<?xml version="1.0" encoding="UTF-8"?>
<p id="p0070">Hepatitis B poses unique challenges to elimination. It is a chronic disease whose mode of transmission, health impact and management change across the lifespan and therefore requires ongoing monitoring throughout its course (
 <xref rid="bib6" ref-type="bibr">6</xref>). Current international hepatitis B management guidelines are complex, as not all patients are currently recommended to have treatment (
 <xref rid="bib7" ref-type="bibr">7</xref>, 
 <xref rid="bib18" ref-type="bibr">18</xref>). Moreover, unlike hepatitis C there is currently no cure, and even when the disease is well-controlled by treatment there remains a residual risk of liver cancer (
 <xref rid="bib19" ref-type="bibr">19</xref>). Key programmatic challenges to elimination are outlined in 
 <bold>Panel 1</bold> (
 <xref rid="bib12" ref-type="bibr">12</xref>).
</p>
